Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

EMEA appoints new head of pharmacovigilance

This article was originally published in Scrip

Executive Summary

Peter Arlett of the European Commissionhas been appointed head of sector for pharmacovigilance and risk management at the European Medicines Agency(EMEA), effective September 16th. Dr Arlett joined the UK Medicines and Healthcare products Regulatory Agency (MHRA) in 1996, and was also a member of the EMEA's scientific committee, the CHMP. He joined the European Commission's pharmaceuticals unit in 2003, and recently helped develop draft legislation on the safety of medicines and pharmacovigilance.

Advertisement
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

SC000416

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel